Large-scale testing (Phase 3)Study completedNCT02662985
What this trial is testing
Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)
Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 166